|
Valeant Pharmaceuticals Completes Syndication of Incremental Term Loans
|
12/23/11
|
Valeant Pharmaceuticals Completes Syndication of Incremental Term Loans
|
PDF
|
|
Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance
|
12/22/11
|
Valeant Pharmaceuticals to Hold Conference Call to Announce 2012 Financial Guidance
|
PDF
|
|
Valeant Pharmaceuticals Completes Acquisition of iNova
|
12/22/11
|
Valeant Pharmaceuticals Completes Acquisition of iNova
|
PDF
|
|
Valeant Pharmaceuticals Completes Acquisition of Dermik
|
12/19/11
|
Valeant Pharmaceuticals Completes Acquisition of Dermik
|
PDF
|
|
Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash
|
12/16/11
|
Valeant Pharmaceuticals Proposes to Acquire ISTA Pharmaceuticals Inc. for $6.50 Per Share in Cash
|
PDF
|
|
Valeant Announces Successful Results From Phase III Onychomycosis Trials
|
12/16/11
|
Valeant Announces Successful Results From Phase III Onychomycosis Trials
|
PDF
|
|
Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
|
12/12/11
|
Valeant Announces the Completion of the Privatization of Afexa Life Sciences Inc.
|
PDF
|
|
Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik
|
12/12/11
|
Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik
|
PDF
|
|
Valeant Pharmaceuticals to Syndicate Incremental Term Loans
|
11/30/11
|
Valeant Pharmaceuticals to Syndicate Incremental Term Loans
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire iNova
|
11/20/11
|
Valeant Pharmaceuticals Agrees to Acquire iNova
|
PDF
|
|
Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
|
11/10/11
|
Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
|
PDF
|
|
Valeant Pharmaceuticals Reports 2011 Third Quarter Financial Results
|
11/03/11
|
Valeant Pharmaceuticals Reports 2011 Third Quarter Financial Results
|
PDF
|
|
Valeant Announces New $1.5 Billion Securities Repurchase Program
|
11/03/11
|
Valeant Announces New $1.5 Billion Securities Repurchase Program
|
PDF
|
|
Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization
|
10/27/11
|
Valeant Announces Take-Up of Additional Afexa Shares and Special Meeting of Shareholders of Afexa to Approve Its Privatization
|
PDF
|
|
Valeant Pharmaceuticals Successfully Completes Refinancing of Senior Secured Credit Facilities
|
10/21/11
|
Valeant Pharmaceuticals Successfully Completes Refinancing of Senior Secured Credit Facilities
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
|
10/21/11
|
Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011
|
PDF
|
|
Valeant Announces Results of Friendly Offer for Afexa Life Sciences Inc.
|
10/18/11
|
Valeant Announces Results of Friendly Offer for Afexa Life Sciences Inc.
|
PDF
|
|
Valeant Announces That Afexa Supports and Recommends Valeant's Increased Offer and Agrees to Certain Amendments to Support Agreement
|
09/30/11
|
Valeant Announces That Afexa Supports and Recommends Valeant's Increased Offer and Agrees to Certain Amendments to Support Agreement
|
PDF
|
|
Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada
|
09/28/11
|
Valeant Pharmaceuticals Announces Approval Of Colesevelam Hydrochloride In Canada
|
PDF
|
|
Valeant Pharmaceuticals Intends to Raise Offer for Afexa Life Sciences Inc. to $0.85 per Share
|
09/26/11
|
Valeant Pharmaceuticals Intends to Raise Offer for Afexa Life Sciences Inc. to $0.85 per Share
|
PDF
|
|
Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities
|
09/26/11
|
Valeant Pharmaceuticals to Refinance Senior Secured Credit Facilities
|
PDF
|
|
Valeant Pharmaceuticals Announces Second Request from the Federal Trade Commission in Connection with Pending Dermatology Acquisitions
|
09/20/11
|
Valeant Pharmaceuticals Announces Second Request from the Federal Trade Commission in Connection with Pending Dermatology Acquisitions
|
PDF
|
|
Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa
|
09/09/11
|
Valeant Pharmaceuticals Announces Mailing of Offer and Take-Over Bid Circular to Shareholders of Afexa
|
PDF
|
|
Valeant Pharmaceuticals to Present at Industry Conferences
|
09/02/11
|
Valeant Pharmaceuticals to Present at Industry Conferences
|
PDF
|
|
Valeant Pharmaceuticals Announces All-Cash Offer to Acquire Afexa Life Sciences Inc.
|
08/30/11
|
Valeant Pharmaceuticals Announces All-Cash Offer to Acquire Afexa Life Sciences Inc.
|
PDF
|
|
Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program
|
08/29/11
|
Valeant Pharmaceuticals Announces Increase to Monetary Limit Under Its Securities Repurchase Program
|
PDF
|
|
Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
|
08/23/11
|
Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
|
PDF
|
|
Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
|
08/19/11
|
Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
|
PDF
|
|
Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeant's Board of Directors
|
08/18/11
|
Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeant's Board of Directors
|
PDF
|
|
Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
|
08/04/11
|
Valeant Pharmaceuticals Reports 2011 Second Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals Appoints Ronald Farmer to Fill Board Vacancy
|
08/03/11
|
Valeant Pharmaceuticals Appoints Ronald Farmer to Fill Board Vacancy
|
PDF
|
|
Valeant Pharmaceuticals International, Inc.
|
08/03/11
|
Valeant Pharmaceuticals International, Inc.
|
PDF
|
|
Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
|
07/25/11
|
Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2011 Second Quarter Results on August 4, 2011
|
07/20/11
|
Valeant Pharmaceuticals to Announce 2011 Second Quarter Results on August 4, 2011
|
PDF
|
|
Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta(TM) in Canada
|
07/19/11
|
Valeant Pharmaceuticals Announces Distribution Agreement for Zuacta(TM) in Canada
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
|
07/15/11
|
Valeant Pharmaceuticals Agrees to Acquire Ortho Dermatologics
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Dermik
|
07/11/11
|
Valeant Pharmaceuticals Agrees to Acquire Dermik
|
PDF
|
|
Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese(TM)
|
06/30/11
|
Valeant Pharmaceuticals Announces License Agreement With Meda for North American Rights for Elidel® and Xerese(TM)
|
PDF
|
|
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga(TM) (ezogabine)
|
06/13/11
|
Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga(TM) (ezogabine)
|
PDF
|
|
Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash
|
05/24/11
|
Valeant Pharmaceuticals Agrees to Acquire Sanitas Group for Approximately EUR314 Million in Cash
|
PDF
|
|
Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
|
05/16/11
|
Kinerase® Introduces "Change Your Skin, Change Your Life" Charity Campaign
|
PDF
|
|
Valeant Pharmaceuticals to Webcast 2011 Annual Meeting of Shareholders
|
05/11/11
|
Valeant Pharmaceuticals to Webcast 2011 Annual Meeting of Shareholders
|
PDF
|
|
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
|
05/09/11
|
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
|
05/02/11
|
Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
|
04/29/11
|
Valeant Pharmaceuticals to Announce 2011 First Quarter Results on May 9, 2011
|
PDF
|
|
Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders
|
04/21/11
|
Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders
|
PDF
|
|
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
|
04/21/11
|
Valeant Pharmaceuticals Responds to Cephalon Board's Letter
|
PDF
|
|
Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
|
04/20/11
|
Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
|
PDF
|
|
Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
|
04/18/11
|
Regulatory Update - GSK and Valeant Respond to FDA on ezogabine
|
PDF
|
|
Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
|
04/18/11
|
Valeant Pharmaceuticals Adds Corporate Governance Expert Abe Friedman to its Slate of Proposed Cephalon Directors
|
PDF
|
|
Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
|
04/11/11
|
Valeant Pharmaceuticals Files Presentation for Cephalon Stockholders
|
PDF
|
|
Meda to License Elidel to Valeant Pharmaceuticals
|
04/07/11
|
Meda to License Elidel to Valeant Pharmaceuticals
|
PDF
|
|
Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
|
04/05/11
|
Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
|
PDF
|
|
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States
|
04/01/11
|
Promius Pharma and Valeant Form Collaboration to Market Cloderm(R) Cream in the United States
|
PDF
|
|
Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
|
03/29/11
|
Valeant Pharmaceuticals Proposes to Acquire Cephalon, Inc. for $73 Per Share in Cash
|
PDF
|
|
GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
|
03/29/11
|
GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
|
PDF
|
|
Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
|
03/22/11
|
Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
|
PDF
|
|
Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
|
03/11/11
|
Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
|
PDF
|
|
Valeant Announces Pricing of Senior Notes
|
03/03/11
|
Valeant Announces Pricing of Senior Notes
|
PDF
|
|
Valeant Launches Senior Notes Offering
|
03/01/11
|
Valeant Launches Senior Notes Offering
|
PDF
|
|
Valeant Pharmaceuticals Reports 2010 Fourth Quarter Financial Results
|
02/24/11
|
Valeant Pharmaceuticals Reports 2010 Fourth Quarter Financial Results
|
PDF
|
|
Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference
|
02/16/11
|
Valeant Pharmaceuticals to Present at RBC Capital Markets' 2011 Healthcare Conference
|
PDF
|
|
Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
|
02/15/11
|
Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
|
PDF
|
|
Valeant Pharmaceuticals Announces Acquisition of Cholestagel(R) in Canada
|
02/10/11
|
Valeant Pharmaceuticals Announces Acquisition of Cholestagel(R) in Canada
|
PDF
|
|
Valeant Pharmaceuticals Announces License Of ACZONE(R) (dapsone) Gel 5% In Canada
|
02/08/11
|
Valeant Pharmaceuticals Announces License Of ACZONE(R) (dapsone) Gel 5% In Canada
|
PDF
|
|
Valeant Launches Senior Notes Offering
|
02/03/11
|
Valeant Launches Senior Notes Offering
|
PDF
|
|
Valeant Announces Pricing of Senior Notes
|
02/03/11
|
Valeant Announces Pricing of Senior Notes
|
PDF
|
|
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R)
|
02/03/11
|
Valeant Pharmaceuticals to Acquire U.S. and Canadian Rights to Zovirax(R)
|
PDF
|
|
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
|
02/01/11
|
Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
|
PDF
|
|
Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
|
01/21/11
|
Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
|
PDF
|
|
Valeant Pharmaceuticals to Present at J.P. Morgan 29th Annual Health Care Conference
|
01/10/11
|
Valeant Pharmaceuticals to Present at J.P. Morgan 29th Annual Health Care Conference
|
PDF
|
